Aidapak Recalls Mesalamine Capsules Due to Potential Label Mixup
Aidapak Services, LLC is recalling Mesalamine CR capsules because they may be mislabeled as clomipramine HCl. The repacked drugs were distributed in four western states.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The hazard is a labeling error (mislabeling) rather than a contamination or structural defect, and no injuries or illnesses are reported in the source text.
Plain-English summary
Aidapak Services, LLC is recalling Mesalamine CR Capsules, 500 mg, NDC 54092019112, due to a potential label mixup. The recall involves repacked drugs that may be mislabeled as clomipramine HCl Capsules, 50 mg, NDC 51672401205. The specific pedigree for the recalled Mesalamine is AD21965_16 with an expiration date of 5/1/2014.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The source text does not specify the exact number of units affected or the specific dates of distribution.
Consumers and healthcare providers should check their inventory for Mesalamine CR Capsules, 500 mg, with the pedigree AD21965_16 and expiration date 5/1/2014. If found, these products should be quarantined and not dispensed. Patients should contact their healthcare provider for guidance if they have received or used these products.
The recalled product
- Product
- MESALAMINE CR Capsule, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 54092019112
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 111
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- MESALAMINE CR
- Capsule
- 500 mg has the following code Pedigree: AD21965_16
- EXP: 5/1/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02